Impact of Diabetes Mellitus on One-Year Clinical Outcomes in Patients Anticoagulated with Bivalirudin Undergoing Elective Percutaneous Coronary Intervention

Impact of Diabetes Mellitus on One-Year Clinical Outcomes in Patients Anticoagulated with Bivalirudin Undergoing Elective Percutaneous Coronary Intervention

Background: Patients with diabetes mellitus (DM) are considered to increase the risk of thrombosis and bleeding. However, whether DM is an independent risk factor for events in patients anticoagulated with bivalirudin during elective percutaneous coronary intervention (PCI) is not clear. Methods: Pa...

Full description

Bibliographic Details
Main Authors: Yulong Li MBBS, Jiawen Li MBBS, Changdong Guan MSc, Shuhong Su MD, Zhifang Wang MD, Haiwei Liu MD, Bo Xu MBBS, Weixian Yang MD, Yuejin Yang MD, Runlin Gao MD, Jinqing Yuan MD, Xueyan Zhao MD
Format: Article
Language:English
Published: SAGE Publishing 2022-08-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/10760296221113344

Internet

https://doi.org/10.1177/10760296221113344

Similar Items